These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10378715)

  • 1. The effects of interferon beta treatment on arthritis.
    Tak PP; Hart BA; Kraan MC; Jonker M; Smeets TJ; Breedveld FC
    Rheumatology (Oxford); 1999 Apr; 38(4):362-9. PubMed ID: 10378715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.
    Smeets TJ; Dayer JM; Kraan MC; Versendaal J; Chicheportiche R; Breedveld FC; Tak PP
    Arthritis Rheum; 2000 Feb; 43(2):270-4. PubMed ID: 10693865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
    Ravandi F; Estrov Z; Kurzrock R; Breitmeyer JB; Maschek BJ; Talpaz M
    Clin Cancer Res; 1999 Dec; 5(12):3990-8. PubMed ID: 10632330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.
    Aalbers CJ; Bevaart L; Loiler S; de Cortie K; Wright JF; Mingozzi F; Tak PP; Vervoordeldonk MJ
    PLoS One; 2015; 10(6):e0130612. PubMed ID: 26107769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
    Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
    Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.
    van Holten J; Pavelka K; Vencovsky J; Stahl H; Rozman B; Genovese M; Kivitz AJ; Alvaro J; Nuki G; Furst DE; Herrero-Beaumont G; McInnes IB; Musikic P; Tak PP
    Ann Rheum Dis; 2005 Jan; 64(1):64-9. PubMed ID: 15242865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial.
    Furuzawa-Carballeda J; Cabral AR; Zapata-Zuñiga M; Alcocer-Varela J
    J Rheumatol; 2003 Feb; 30(2):256-9. PubMed ID: 12563677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model.
    Zhao R; Chen NN; Zhou XW; Miao P; Hu CY; Qian L; Yu QW; Zhang JY; Nie H; Chen XH; Li P; Xu R; Xiao LB; Zhang X; Liu JR; Zhang DQ
    J Transl Med; 2014 Dec; 12():330. PubMed ID: 25491303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys.
    Brok HP; Tekoppele JM; Hakimi J; Kerwin JA; Nijenhuis EM; De Groot CW; Bontrop RE; 't Hart BA
    Clin Exp Immunol; 2001 Apr; 124(1):134-41. PubMed ID: 11359452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5.
    Vierboom MP; Zavodny PJ; Chou CC; Tagat JR; Pugliese-Sivo C; Strizki J; Steensma RW; McCombie SW; Celebi-Paul L; Remarque E; Jonker M; Narula SK; Hart B
    Arthritis Rheum; 2005 Feb; 52(2):627-36. PubMed ID: 15693002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
    Gerber LH; Furst G; Yarboro C; el-Gabalawy H
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture for symptom management of rheumatoid arthritis: a pilot study.
    Lee H; Lee JY; Kim YJ; Kim S; Yin C; Khil JH; Kwon K; Choi SM; Lee H; Park HJ
    Clin Rheumatol; 2008 May; 27(5):641-5. PubMed ID: 18193382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis.
    Ueki Y; Yamasaki S; Kanamoto Y; Kawazu T; Yano M; Matsumoto K; Miyake S; Tominaga Y; Iwamoto U; Suemitsu J; Matsuno Y; Sizume Y; Takenaka Y; Eguchi K
    Rheumatology (Oxford); 2000 Feb; 39(2):165-71. PubMed ID: 10725066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis.
    Paulus HE; Bulpitt KJ; Ramos B; Park G; Wong WK;
    Arthritis Rheum; 2000 Dec; 43(12):2743-50. PubMed ID: 11145032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental immune mediated arthritis in rhesus monkeys. A model for human rheumatoid arthritis?
    Bakker NP; van Erck MG; Zurcher C; Faaber P; Lemmens A; Hazenberg M; Bontrop RE; Jonker M
    Rheumatol Int; 1990; 10(1):21-9. PubMed ID: 2353150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic effect of interferon-gamma in murine collagen-induced arthritis.
    Boissier MC; Chiocchia G; Bessis N; Hajnal J; Garotta G; Nicoletti F; Fournier C
    Eur J Immunol; 1995 May; 25(5):1184-90. PubMed ID: 7774621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis.
    Paran D; Elkayam O; Mayo A; Paran H; Amit M; Yaron M; Caspi D
    Ann Rheum Dis; 2001 Sep; 60(9):888-91. PubMed ID: 11502617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.